1. Home
  2. ABR vs RLAY Comparison

ABR vs RLAY Comparison

Compare ABR & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$7.35

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.35

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
RLAY
Founded
2003
2015
Country
United States
United States
Employees
653
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ABR
RLAY
Price
$7.35
$9.35
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$10.30
$16.86
AVG Volume (30 Days)
3.7M
2.4M
Earning Date
05-01-2026
05-04-2026
Dividend Yield
16.33%
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$324.03
P/E Ratio
$9.29
N/A
Revenue Growth
N/A
53.44
52 Week Low
$7.11
$1.78
52 Week High
$12.58
$11.49

Technical Indicators

Market Signals
Indicator
ABR
RLAY
Relative Strength Index (RSI) 41.21 44.95
Support Level $7.23 $9.06
Resistance Level $7.95 $9.54
Average True Range (ATR) 0.22 0.63
MACD -0.06 -0.14
Stochastic Oscillator 2.22 0.90

Price Performance

Historical Comparison
ABR
RLAY

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: